Justin Leong is Chief Product Officer of RESMED INC. Currently has a direct ownership of 27,878 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Aug 15, 2024, when has been sold 9,137 shares (ReMed Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.9K
58.23% 3M change
58.23% 12M change
Total Value Held $0

Justin Leong Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 15 2024
BUY
Grant, award, or other acquisition
-
9,137 Added 24.68%
27,878 ReMed Common Stock
Aug 05 2024
SELL
Open market or private sale
$10,419,360 $217.07 p/Share
48,000 Reduced 71.92%
18,741 ReMed Common Stock
Nov 23 2022
BUY
Grant, award, or other acquisition
-
6,924 Added 9.4%
66,741 ReMed Common Stock
Nov 22 2022
SELL
Open market or private sale
$866,821 $229.5 p/Share
3,777 Reduced 5.94%
59,817 ReMed Common Stock
Nov 22 2022
BUY
Exercise of conversion of derivative security
$866,400 $57.76 p/Share
15,000 Added 19.09%
63,594 ReMed Common Stock
Nov 24 2021
SELL
Payment of exercise price or tax liability
$341,191 $254.81 p/Share
1,339 Reduced 2.69%
48,391 ReMed Common Stock
Nov 18 2021
BUY
Grant, award, or other acquisition
-
638 Added 1.25%
50,495 ReMed Common Stock
Nov 16 2021
BUY
Grant, award, or other acquisition
$2,334,569 $254.81 p/Share
9,162 Added 15.52%
49,857 ReMed Common Stock
Aug 19 2021
BUY
Grant, award, or other acquisition
-
2,631 Added 6.07%
40,695 ReMed Common Stock
Jan 18 2021
BUY
Grant, award, or other acquisition
-
865 Added 2.22%
38,064 ReMed Common Stock
Nov 17 2020
BUY
Grant, award, or other acquisition
$2,536,724 $214.74 p/Share
11,813 Added 24.1%
37,199 ReMed Common Stock
Nov 05 2020
SELL
Open market or private sale
$1,635,926 $211.36 p/Share
7,740 Reduced 23.37%
25,386 ReMed Common Stock
Nov 05 2020
BUY
Exercise of conversion of derivative security
$447,062 $57.76 p/Share
7,740 Added 18.94%
33,126 ReMed Common Stock
JL

Justin Leong

Chief Product Officer
San Diego, CA

Track Institutional and Insider Activities on RSMDF

Follow RESMED INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RSMDF shares.

Notify only if

Insider Trading

Get notified when an Resmed Inc insider buys or sells RSMDF shares.

Notify only if

News

Receive news related to RESMED INC

Track Activities on RSMDF